Abstract: Objective To explore a FOCUS-PDCA cycle approach to improve reporting of adverse reactions to blood transfusion. Methods The FOCUS-PDCA cycle approach was applied to continuously improve the reporting process of adverse reactions associated with transfusion in 2019 versus transfusion cases from 2015 to 2018 in the control group. Results Through the establishment of a novel system for reporting adverse transfusion reactions, the target value was set at 100%. The implementation rate of adverse reactions gradually increased to 98% by FOCUS-PDCA cycle approach. The incidence of adverse reactions increased to 0.74%, with statistically significant differences compared to the previous year (χ2=81.64,P<0.05). Conclusion The application of the FOCUS -PDCA cycle approach significantly improved the execution rate of adverse transfusion reactions reported. It plays an important role in clinical blood transfusion quality management and is worthy of promotion.

Key words: FOCUS-PDCA, cycle, approach, Transfusion, reactions, Report, execution, rate